Explore all subjects

The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

Study Group: Physicians Who Treat Psoriatic Nail Disorders (US)(?)

Council Members in this Study Group: 12

This study group may include physicians, care providers, and researchers specializing in internal medicine, cardiology, oncology, dermatology, emergency medicine, family medicine, neurology, obstetrics-gynecology, psychiatry, radiology, nursing, optometry, genetics, and mental health. It may also include experts knowledgeable on diagnostic labs, disease management, medical devices, long term care, surgery centers, health management, pharma, and biotechnology, among others.

Request a survey with this Study Group







Leading Experts in this Study Group

Sunil Dhawan, MD, Clinical Assistant Professor of Dermatology, Stanford UniversitySunil Dhawan, MD
Clinical Assistant Professor of Dermatology
Stanford University

Sunil Dhawan, MD, is a Clinical Assistant Professor of Dermatology at Stanford University. He has expertise in clinical dermatology including acne, rosacea, psoriasis, eczema, skin cancer, actinic keratosis, lasers and cosmetic dermatology, and managed care. Dr. Dhawan also runs the clinical trial division...

Alan Fleischer, MD
Professor and Chair of Dermatology
Wake Forest University School of Medicine - CC

Alan Fleischer, MD, is Professor and Chair of Dermatology at the Wake Forest University School of Medicine. In addition to his general and surgical dermatology practice, he has been primary investigator on dozens of Phase I through Phase IV clinical trials. Dr. Fleischer has published extensively on...

GLG NewsSMAnalyses by this Study Group's Leading Experts(?)

Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.
By Sunil Dhawan, MD, Clinical Assistant Professor of Dermatology, Stanford University
Analysis of: FDA Faults Wrinkle Fillers Over Warnings | online.wsj.com

This article is important in that it discusses a rare but known side effect of filler injections- reactions to these agents. These reactions include allergies, infections, etc. The incidence is low- approximately 1000 cases out of 1.5 million injections. The majority of these reactions were not serious....

By Sunil Dhawan, MD, Clinical Assistant Professor of Dermatology, Stanford University
Analysis of: As Doctors Cater to Looks, Skin Patients Wait | www.nytimes.com

 This article is important in that it describes a growing trend among dermatologists to offer a higher level of "customer service" for their cash paying cosmetic patients. This has contributed in a small way to the long waits for non cosmetic dermatology patients to be able to see a dermatologist....

By Sunil Dhawan, MD, Clinical Assistant Professor of Dermatology, Stanford University
Analysis of: Patients Curb Prescription Spending | online.wsj.com

This article is important in that it describes a worrying trend for branded  pharmaceutical companies. As copays for branded products go up and the patients economic status worsens, the use of these drugs will fall. This may be especially true for medications in dermatology, where the perceived...

By Sunil Dhawan, MD, Clinical Assistant Professor of Dermatology, Stanford University

This article is important in that it confirms a commonly used method in clinical dermatology practice. Namely that of using Protopic for longer term maintenance to prevent flares, and to act as a topical steroid sparing agent. This has been done since the introduction of Protopic, and among dermatologists...

By Sunil Dhawan, MD, Clinical Assistant Professor of Dermatology, Stanford University
Analysis of: One drug, many uses. Good idea? | www.indystar.com

This article is important because it describes a growing concern that is not well known to the investment community or the public. Due to increased pressure from the generic companies, the FDA, and the public many companies are finding new uses for older medications. This is very true in dermatology...

View All GLG News by members of this Study Group

Most Common Company Types:

  • Office Based Private Practice or Clinic
  • Academic Medical Center/Hospital or Clinic
  • Academic Institution*

Most Common Job Types:

  • Physician - Attending Physician
  • Owner
  • Physician - Department Chair
  • Assistant Professor
  • Physician - Director
  • Physician - Division Head

GLG's 850+ Clients Include:

Fortune 500®  companies
40 of the leading 50  global mutual funds
15 of the leading 20  global banks
8 of the leading 10  global private equity firms
5 of the top 10  AmLaw firms

Analytics


Generated at 2009-01-08T19:00:17.880